Selva-Sevilla Carmen, Ferrara Paula, Gerónimo-Pardo Manuel
Department of Applied Economy, Faculty of Economic Sciences of Albacete, University of Castilla La-Mancha.
Departments of Neurosurgery.
Clin Spine Surg. 2019 Jun;32(5):E228-E234. doi: 10.1097/BSD.0000000000000797.
This study was an ambispective long-term cost-utility analysis with retrospective chart review and included the prospective completion of health questionnaires by patients.
This was a cost-utility analysis, comparing conservative treatment, discectomy, and discectomy with spinal fusion for patients with recurrent lumbar disc herniation after a previous discectomy.
Lumbar disc herniation is an important health problem, with recurrence rates ranging from 5% to 15%. Management of recurrences is controversial due to a lack of high-level evidence. Cost-effectiveness analyses are useful when making clinical decisions. There are economic assessments for first herniations, but not in the context of recurrent lumbar disc herniations.
Fifty patients with disc herniation recurrence underwent conservative treatment (n=11), discectomy (n=20), or discectomy with fusion (n=19), and they completed the Short-Form 36, EuroQol-5D, and Oswestry Disability Index.Baseline case quality-adjusted life year (QALY) values, cost-utility ratios, and incremental cost-utility ratios were calculated on the basis of the SF-36. Direct health costs were calculated by applying the health care system perspective. Both QALY and costs were discounted at a rate of 3%. One-way sensitivity analyses were conducted for uncertainty variables, such as other health surveys or 2-year follow-up.
Cost-utility analysis of conservative treatment versus discectomy showed that the former is dominant, mainly because it is significantly more economical (&OV0556;904 vs. &OV0556;6718, P<0.001), while health results were very similar (3.48 vs. 3.18, P=0.887). Cost-utility analysis of discectomy versus discectomy with fusion revealed that discectomy is dominant, showing a trend to be both more economical (&OV0556;6718 vs. &OV0556;9364, P=0.054) and more effective (3.18 vs. 1.92 QALY, P=0.061).
This cost-utility analysis showed that conservative treatment is more cost-effective than discectomy in patients with lumbar disc herniation recurrence. In cases of recurrence in which conservative treatment is not feasible, and another surgery must be performed for the patient, discectomy is a more cost-effective surgical alternative than discectomy with fusion.
Level II.
本研究是一项采用回顾性病历审查的双向长期成本效用分析,包括患者前瞻性完成健康问卷。
本研究为成本效用分析,比较保守治疗、椎间盘切除术以及椎间盘切除联合脊柱融合术对既往行椎间盘切除术后复发的腰椎间盘突出症患者的疗效。
腰椎间盘突出症是一个重要的健康问题,复发率为5%至15%。由于缺乏高级别证据,复发的治疗存在争议。成本效益分析在临床决策中很有用。有针对首次椎间盘突出症的经济评估,但没有针对复发性腰椎间盘突出症的。
50例椎间盘突出症复发患者接受了保守治疗(n = 11)、椎间盘切除术(n = 20)或椎间盘切除联合融合术(n = 19),并完成了简明健康状况调查问卷(Short-Form )、欧洲五维健康量表(EuroQol-5D)和Oswestry功能障碍指数。根据简明健康状况调查问卷计算基线病例质量调整生命年(QALY)值、成本效用比和增量成本效用比。从医疗保健系统角度计算直接医疗成本。QALY和成本均按3%的贴现率贴现。对不确定性变量进行单向敏感性分析,如其他健康调查或2年随访。
保守治疗与椎间盘切除术的成本效用分析表明,前者占主导地位,主要是因为它明显更经济(904欧元对6718欧元,P < 0.001),而健康结果非常相似(3.48对3.18,P = 0.887)。椎间盘切除术与椎间盘切除联合融合术的成本效用分析表明,椎间盘切除术占主导地位,显示出更经济(6718欧元对9364欧元,P = 0.054)且更有效的趋势(3.18对1.92 QALY,P = 0.061)。
本成本效用分析表明,对于复发性腰椎间盘突出症患者,保守治疗比椎间盘切除术更具成本效益。在保守治疗不可行且必须为患者进行再次手术的复发病例中,椎间盘切除术是比椎间盘切除联合融合术更具成本效益的手术选择。
二级。